Neuroimaging endpoints in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative, clinically heterogeneous syndrome pathologically overlapping with frontotemporal dementia. To date, therapeutic trials in animal models have not been able to predict treatment response in humans, and the revised Amyotrophic Late...
Главные авторы: | Menke, R, Agosta, F, Grosskreutz, J, Filippi, M, Turner, M |
---|---|
Формат: | Journal article |
Опубликовано: |
Springer Verlag
2016
|
Схожие документы
-
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2011) -
Neuroimaging in amyotrophic lateral sclerosis.
по: Turner, M, и др.
Опубликовано: (2012) -
Basal ganglia alterations in amyotrophic lateral sclerosis
по: Veronica Castelnovo, и др.
Опубликовано: (2023-04-01) -
The tough body at the epicentre of amyotrophic lateral sclerosis
по: Turner, M, и др.
Опубликовано: (2017) -
Structural and functional neuroimaging in amyotrophic lateral sclerosis
по: Ilya S. Bakulin, и др.
Опубликовано: (2017-08-01)